Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients With Type 2 Diabetes

NCT04017221 · clinicaltrials.gov ↗

COMPLETED

Status

1249636

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Urosepsis
Diabetic Ketoacidosis
Lower Extremity Amputation

Interventions

DRUG: Sodium-glucose cotransporter 2 (SGLT2) inhibitors
DRUG: Dipeptidyl peptidase-4 (DPP-4) inhibitors
DRUG: Other treatment combinations

Sponsor

Canadian Network for Observational Drug Effect Studies, CNODES

Collaborators

[object Object]
[object Object]